Suppr超能文献

多功能角鲨烯:用于药物纳米粒子的功能涂层。

Multifunctional hydrophobin: toward functional coatings for drug nanoparticles.

机构信息

Division of Pharmaceutical Technology, P.O. Box 56, FI-00014, University of Helsinki, Finland.

出版信息

ACS Nano. 2010 Mar 23;4(3):1750-8. doi: 10.1021/nn9017558.

Abstract

Efficient delivery of nanosized drug formulations to the desired body sites is not always reached despite the rapid development of pharmaceutical nanotechnologies. In spite of the undoubted effect of the size for increased bioavailability and controlled drug delivery, submicrometer formulations also require a deeper level of design. The surface properties of the particles determine the stability of the particles, interactions with the body, and targeting potentials of drugs. Thus, the efficacy of the drug can be increased utilizing the surface layer of the nanoparticles. Influencing the surface characters of the drug is the main focus of the present work, which introduces a method for preparing nanoparticles with functional sites from low-solubility drugs using hydrophobin (HFB) proteins. Particles were prepared by precipitating a lipophilic drug (beclomethasone dipropionate) in water in the presence of the HFB proteins. Particle size below 200 nm could easily be reached with increasing HFB concentration. The particles were shown to be stable for at least 5 h in suspension, and they could be stored for longer periods of time after freeze-drying. Labeling studies using green fluorescent protein (GFP) genetically fused to a HFB clearly demonstrated that the surface of the nanoparticles was covered with the hydrophobins and that the surface could be further modified by utilizing fusion proteins. This provides a template for a variety of different functional surface-bound groups that could be tailored by modifying the hydrophilic side of the HFB via protein bioengineering. In this study, the combination of proteins and traditional pharmaceutical technology was used to synthesize functionalized protein-coated nanoparticles for drug delivery purposes.

摘要

尽管药物制剂纳米技术发展迅速,但纳米药物制剂仍难以有效地递送到所需的体内部位。尽管粒径的增加确实会提高生物利用度和控制药物释放,但亚微米制剂也需要更深入的设计。颗粒的表面性质决定了颗粒的稳定性、与身体的相互作用以及药物的靶向潜力。因此,可以利用纳米颗粒的表面层来提高药物的疗效。影响药物表面性质是本工作的主要关注点,本工作介绍了一种使用亲脂性药物(丙酸倍氯米松)和疏水蛋白(HFB)制备具有功能位点的纳米粒子的方法。通过在 HFB 蛋白存在的情况下将亲脂性药物(丙酸倍氯米松)沉淀在水中来制备颗粒。随着 HFB 浓度的增加,很容易达到粒径低于 200nm 的要求。结果表明,颗粒在悬浮液中至少稳定 5 小时,并且在冷冻干燥后可以储存更长时间。使用与 HFB 基因融合的绿色荧光蛋白(GFP)进行的标记研究清楚地表明,纳米颗粒的表面覆盖有疏水蛋白,并且可以通过利用融合蛋白进一步修饰表面。这为各种不同的功能表面结合基团提供了模板,通过通过蛋白质生物工程修饰 HFB 的亲水侧,可以对其进行定制。在这项研究中,蛋白质和传统药物制剂技术的结合被用于合成用于药物递送目的的功能化蛋白涂层纳米颗粒。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验